article thumbnail

Aspiration of thrombus for intermediate-risk subacute pulmonary embolism

Journal of Cardiothoracic Surgery

Pulmonary embolism is the most common cardiovascular disease after myocardial infarction and stroke. Konstantinides (Eur Heart J 41(4):543–603, 2020) Current guidelines categorize patients with PE as being at.

article thumbnail

Myocardial infarction due to coronary embolism after mechanical aortic valve replacement: a case report

Journal of Cardiothoracic Surgery

Prosthetic valve thrombosis (PVT) in aortic valve and its complication coronary embolism is a very rare condition. We present a young patient with acute myocardi. Diagnosis and treatment process is challenging.

article thumbnail

Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease Due to Coronary Embolism Clarified by Cardiac Computed Tomography

Circulation: Cardiovascular Imaging

Circulation: Cardiovascular Imaging, Ahead of Print.

article thumbnail

Case Report: A 42-year-old male with IABP developing multiple organ embolism and intestinal necrosis

Frontiers in Cardiovascular Medicine

We report a 42-year-old male patient who was diagnosed with acute myocardial infarction (AMI), and subsequently underwent percutaneous coronary intervention (PCI) for revascularization. Then the patient experienced the most severe complications of IABP, including multiple organ embolism and intestinal necrosis.

article thumbnail

Polygenic Risk and Cardiovascular Event Risk in Patients With Atrial Fibrillation With Low to Intermediate Stroke Risk

Journal of the American Heart Association

Patients were stratified according to polygenic risk score tertiles and observed for the occurrence of ischemic stroke or systemic embolism, myocardial infarction, and heart failure hospitalization. P=0.011) for ischemic stroke or systemic embolism, 1.15 (95% CI, 0.821.61;P=0.422) During a median followup of 4.6

article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

ET Main Tent (Hall B1) - A Double-blind, Randomized Placebo Procedure-controlled Trial of an Interatrial Shunt in Patients with HFrEF and HFpEF: Principal Results From the RELIEVE-HF Trial - Empagliflozin After Acute Myocardial Infarction: Results of the EMPACT-MI Trial - CSL112 (Apolipoprotein A-I) Infusions and Cardiovascular Outcomes in Patients (..)

article thumbnail

Interventional thrombus modification in STEMI

Nature Reviews - Cardiology

Nature Reviews Cardiology, Published online: 02 April 2024; doi:10.1038/s41569-024-01020-2 In ST-segment elevation myocardial infarction, the role of interventional modification of thrombi in the coronary arteries before stenting is controversial.

STEMI 40